Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
100.49
+6.69 (7.13%)
At close: Dec 5, 2025, 4:00 PM EST
102.49
+2.00 (1.99%)
After-hours: Dec 5, 2025, 5:49 PM EST
Palvella Therapeutics Stock Forecast
Stock Price Forecast
According to 16 professional analysts, the 12-month price target for Palvella Therapeutics stock ranges from a low of $38 to a high of $200. The average analyst price target of $124.25 forecasts a 23.64% increase in the stock price over the next year.
Price Target: $124.25 (+23.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palvella Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 8 | 9 | 12 |
| Buy | 1 | 3 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 11 | 12 | 12 | 13 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Strong Buy Initiates $200 | Strong Buy | Initiates | $200 | +99.02% | Dec 5, 2025 |
| BTIG | BTIG | Strong Buy Initiates $167 | Strong Buy | Initiates | $167 | +66.19% | Dec 5, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $175 | Strong Buy | Initiates | $175 | +74.15% | Dec 4, 2025 |
| Stifel | Stifel | Strong Buy Maintains $87 → $145 | Strong Buy | Maintains | $87 → $145 | +44.29% | Nov 24, 2025 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $92 → $143 | Buy → Strong Buy | Upgrades | $92 → $143 | +42.30% | Nov 19, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
40.80K
EPS This Year
-3.56
from -7.83
EPS Next Year
-3.91
from -3.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 420,000 | ||||
| Avg | n/a | 40,800 | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.98 | -2.99 | ||||
| Avg | -3.56 | -3.91 | ||||
| Low | -3.57 | -4.82 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.